Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 4/20 | 0.36 |
| ▸ | GSR | P00390 | 1/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.31 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.30 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.30 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL94212 | 0.81 | TSHR (0.44) | TSHRALDH1A1OR51E2LMNA | |
| SCHEMBL8346659 | 0.78 | TSHR (0.41) | TSHRALDH1A1OR51E2LMNA | |
| Ammonia Solution, Strong SCHEMBL8353342 | 0.78 | TSHR (0.41) | TSHRALDH1A1OR51E2LMNA | |
| Ammonia Solution, Strong SCHEMBL714830 | 0.78 | TSHR (0.41) | TSHRALDH1A1OR51E2LMNA | |
| SCHEMBL8351174 | 0.78 | TSHR (0.41) | TSHRALDH1A1OR51E2LMNA | |
| Trolamine SCHEMBL8354308 | 0.76 | KDM4E (0.34) | OR51E2 | |
| Cadaverine Tartrate SCHEMBL1834853 | 0.76 | TSHR (0.59) | TSHRALDH1A1OR51E2GABRR1GSR | |
| Cadaverine Tartrate SCHEMBL1833811 | 0.76 | TSHR (0.59) | TSHRALDH1A1OR51E2GABRR1GSR | |
| Tartaric Acid SCHEMBL31538119 | 0.76 | TSHR (0.59) | TSHRALDH1A1OR51E2GABRR1GSR | |
| Lactic Acid SCHEMBL22346344 | 0.74 | TP53 (0.61) | TSHRALDH1A1OR51E2GABRR1GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4593786-A1 | STABLE SKIN CARE COMPOSITIONS CONTAINING A RETINOID | The Procter & Gamble Company (US) | 2025-08-06 | — | — | EP | claimed |
| WO-2024073219-A1 | STABLE SKIN CARE COMPOSITIONS CONTAINING A RETINOID | THE PROCTER & GAMBLE COMPANY (US) | 2024-04-04 | — | — | WO | claimed |
| US-20240099944-A1 | Stable Skin Care Compositions Containing a Retinoid | THE PROCTER & GAMBLE COMPANY | 2024-03-28 | — | — | US | claimed |
| US-20120171156-A1 | METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES | HDS LTD. (GB) | 2012-07-05 | — | — | US | claimed |
| EP-2442873-A2 | METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES | Hds Limited (GB) | 2012-04-25 | — | — | EP | claimed |
| WO-2010146142-A9 | METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES | HDS LIMITED (GB) | 2011-06-16 | — | — | WO | claimed |
| WO-2010146142-A2 | METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES | HDS LIMITED (GB) | 2010-12-23 | — | — | WO | claimed |
| US-5925366-A | PERMEATION/BINDING AGENT, THIO CROSSLINKING AGENT, AND CHELATE COMPOUND | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1999-07-20 | — | — | US | claimed |
| US-5785959-A | MIXTURE CONTAINING A PERMEATION/BINDING AGENT, A THIO CROSSLINKING AGENT, A CHELATING AGENT, WATER AND AN OIL | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-07-28 | — | — | US | claimed |
| WO-1998006376-A1 | NAIL STRENGTHENING COMPOSITIONS AND A METHOD FOR STRENGTHENING NAILS | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-02-19 | — | — | WO | claimed |
| US-20250302710-A1 | SKIN CARE COMPOSITIONS CONTAINING A RETINOID WITH REDUCED MALODOR | THE PROCTER & GAMBLE COMPANY | 2025-10-02 | — | — | US | disclosed |
| EP-4593786-A1 | STABLE SKIN CARE COMPOSITIONS CONTAINING A RETINOID | The Procter & Gamble Company (US) | 2025-08-06 | — | — | EP | disclosed |
| EP-4464307-A1 | COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME | MPLUS COSMETICS S.R.L. (IT) | 2024-11-20 | — | — | EP | disclosed |
| US-20240374498-A1 | COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME | MPLUS COSMETICS S.R.L. (IT) | 2024-11-14 | — | — | US | disclosed |
| WO-2024073219-A1 | STABLE SKIN CARE COMPOSITIONS CONTAINING A RETINOID | THE PROCTER & GAMBLE COMPANY (US) | 2024-04-04 | — | — | WO | disclosed |
| US-20040052748-A1 | Compositions of anionic polymeric rheology modifiers and cationic materials | LUBRIZOL ADVANCED MATERIALS, INC. | 2004-03-18 | — | — | US | disclosed |
| US-5993794-A | CONTAINING 2-7% OF THIOGLYCOLIC ACID, SALT OF THIOGLYCOLIC ACID, CYSTEINE AND/OR ACETYL CYSTEINE AND 1.5-17.5% OF DITHIODIGLYCOLIC ACID, ACID AND/OR CYSTINE | TAKARA BELMONT KABUSHIKI KAISHA (JP) | 1999-11-30 | — | — | US | disclosed |
| US-5925366-A | PERMEATION/BINDING AGENT, THIO CROSSLINKING AGENT, AND CHELATE COMPOUND | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1999-07-20 | — | — | US | disclosed |
| US-5785959-A | MIXTURE CONTAINING A PERMEATION/BINDING AGENT, A THIO CROSSLINKING AGENT, A CHELATING AGENT, WATER AND AN OIL | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-07-28 | — | — | US | disclosed |
| WO-1998006376-A1 | NAIL STRENGTHENING COMPOSITIONS AND A METHOD FOR STRENGTHENING NAILS | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302710-A1 | SKIN CARE COMPOSITIONS CONTAINING A RETINOID WITH REDUCED MALODOR | RBP4, RARA, RBP1 | TSHR 2099/4885ALDH1A1 20/4885OR51E2 188/4885 |
| US-20040052748-A1 | Compositions of anionic polymeric rheology modifiers and cationic materials | PBRM1, PARG, PARN | TSHR 3332/4885ALDH1A1 4839/4885OR51E2 1626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.